Latest News & Features
Biotechnology
UK IP firm Marks & Clerk LLP has announced two of its attorneys will be joining the firm’s partnership. 28 August 2013
Big Pharma
Austria has become the first country in the EU to ratify consent to the Unified Patent Court. 27 August 2013
Americas
US law firm Miles & Stockbridge PC has continued the expansion of its IP practice with the addition of seven lawyers and one patent agent. 23 August 2013
Americas
Eli Lilly has begun its defence of a patent covering lung cancer drug Alimta against generic companies including Teva, Barr Laboratories and APP Pharmaceuticals. 23 August 2013
Americas
US-based Horizon Pharma Inc agreed on August 22 to settle its patent dispute over arthritis drug Duexis with generic maker Par Pharmaceutical Companies. 22 August 2013
Asia
Drugmaker Roche has decided not to pursue a patent application for a breast cancer drug in the Indian market, enabling rivals to possibly produce cheaper versions. 19 August 2013
Americas
Texas-based Almha has launched patent infringement lawsuits against four companies, including UK company Allergan, in relation to its patent covering a “breast implant with position lock”. 14 August 2013
Americas
Lorna Tanner has joined the Palo Alto office of Sheppard Mullin Richter & Hampton LLP as an IP partner. 14 August 2013
Asia
The Chinese State Intellectual Property Office (SIPO) has revoked a patent covering biopharmaceutical company Gilead Science’s HIV drug Viread, Reuters subsidiary news site BioWorld reported. 13 August 2013
Asia
On August 8 the IPAB revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan. 12 August 2013